Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06422143
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-05-15
Brief Title:
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan Sac-TMT MK-2870 in Metastatic Squamous Non-small Cell Lung Cancer NSCLC MK-2870-023
Sponsor:
Organization:
Merck Sharp Dohme LLC